Fellows National Video Conference Series Articles

April 2014

 

Analysis of Prognostic Factors Impacting Oncologic Outcomes After Neoadjuvant Tyrosine Kinase Inhibitor Therapy for Gastrointestinal Stromal Tumors

Brian K. Bednarski, MD, Dejka M. Araujo, MD, Min Yi, MD, PhD, Keila E. Torres, MD, PhD, Alexander Lazar, MD, PhD, Jonathan C. Trent, MD, PhD, Janice N. Cormier, MD, MPH, Peter W. T. Pisters, MD, Dina Chelouche Lev, MD, Raphael E. Pollock, MD, PhD, Barry W. Feig, MD, and Kelly K. Hunt, MD
Download PDF

One vs Three Years of Adjuvant Imatinib for Operable Gastrointestinal Stromal Tumor - A Randomized Trial

Heikki Joensuu, MD, Mikael Eriksson, MD, Kirsten Sundby Hall, MD, Jorg T. Hartmann, MD, Daniel Pink, MD, Jochen Schutte, MD, Giuliano Ramadori, MD, Peter Hohenberger, MD, Justus Duyster, MD, Salah-Eddin Al-Batran, MD, Marcus Schlemmer, MD, Sebastian Bauer, MD, Eva Wardelmann, MD, Maarit Sarlomo-Rikala, MD, Bengt Nilsson, MD, Harri Sihto, MSc, Odd R. Monge, MD, Petri Bono, MD, Raija Kallio, MD, Aki Vehtari, DSc, Mika Leinonen, MSc, Thor Alvegard, MD, Peter Reichardt, MD
Download PDF

Efficacy and safety of regorafenib for advanced gastrointestinal stromal tumours after failure of imatinib and sunitinib (GRID): an international, multicentre, randomised, placebo-controlled, phase 3 trial

George D Demetri, Peter Reichardt, Yoon-Koo Kang, Jean-Yves Blay, Piotr Rutkowski, Hans Gelderblom, Peter Hohenberger, Michael Leahy, Margaret von Mehren, Heikki Joensuu, Giuseppe Badalamenti, Martin Blackstein, Axel Le Cesne, Patrick Schöff ski, Robert G Maki, Sebastian Bauer, Binh Bui Nguyen, Jianming Xu, Toshirou Nishida, John Chung, Christian Kappeler, Iris Kuss, Dirk Laurent, Paolo G Casali, on behalf of all GRID study investigators
Download PDF

Contemporary Results with Ampullectomy for 29 “Benign” Neoplasms of the Ampulla

Stephen R Grobmyer, MD, Chad N Stasik, MD, Peter Draganov, MD, AlanW Hemming, MD, FACS, Lisa R Dixon, MD, Stephen B Vogel, MD, FACS, Steven N Hochwald, MD, FACS
Download PDF

Prediction of Carcinoma After Resection in Subjects With Ampullary Adenomas on Endoscopic Biopsy

Ha-Na Kim, MD, Kwang Min Kim, MD, Jae Uk Shin, MD, Jong Kyun Lee, MD, PhD, Kyu Taek Lee, MD, PhD, Kwang Hyuk Lee, MD, PhD, Kyoung Mee Kim, MD, PhD, and Jae Hoon Lim, MD
Download PDF

Effect of Adjuvant Chemotherapy With Fluorouracil Plus Folinic Acid or Gemcitabine vs Observation on Survival in Patients With Resected Periampullary Adenocarcinoma

The ESPAC-3 Periampullary Cancer Randomized Trial

John P. Neoptolemos, MD, Malcolm J. Moore, MD, Trevor F. Cox, PhD, Juan W. Valle, MD, Daniel H. Palmer, MD, Alexander C. McDonald, MD, Ross Carter, MD, Niall C. Tebbutt, PhD, Christos Dervenis, MD, David Smith, MD, Bengt Glimelius, MD, Richard M. Charnley, MD, Francois Lacaine, MD, Andrew G. Scarfe, MD, Mark R. Middleton, MD, Alan Anthoney, MD, Paula Ghaneh, MD, Christopher M. Halloran, MD, Markus M. Lerch, MD, Attila Olah, MD, Charlotte L. Rawcliffe, MSc, Caroline S. Verbeke, MD, FRCPath. Fiona Campbell, MD, FRCPath, Markus W. Buchler, MD
Download PDF

Stage-Stratified Prognosis of Signet Ring Cell Histology in Patients Undergoing Curative Resection for Gastric Adenocarcinoma

Zubin M. Bamboat, MD, Laura H. Tang, MD, PhD, Eduardo Vinuela, MD, Deborah Kuk, MS, Mithat Gonen, PhD, Manish A. Shah, MD, Murray F. Brennan, MD, Daniel G. Coit, MD, and Vivian E. Strong, MD
Download PDF

Is Preoperative Chemotherapy Followed by Surgery the Appropriate Treatment for Signet Ring Cell Containing Adenocarcinomas of the Esophagogastric Junction and Stomach?

Ulrike Heger, MD, Susanne Blank, MD, Christiane Wiecha, MS, Rupert Langer, MD, Wilko Weichert, MD, Florian Lordick, MD, Thomas Bruckner, PhD, Martin Dobritz, MD, Maria Burian, MD, Christoph Springfeld, MD, PhD, Lars Grenacher, MD, Jorg-Rudiger Siewert, MD, Markus Buchler, MD, and Katja Ott, MD
Download PDF

Prognostic Significance of Signet Ring Gastric Cancer

Sharven Taghavi, Senthil N. Jayarajan, Adam Davey, and Alliric I. Willis
Download PDF